Immunohistochemical predictors of local recurrence in breast carcinoma: development and sensitivity validation of an IHC-based risk score.
A pragmatic IHC-based risk score based on routinely available biomarkers stratified local recurrence risk in breast cancer patients treated with BCS and remained stable under sensitivity testing. External validation in larger, multicenter cohorts is warranted.
Authors
- Liliana Cercelaru (ORCID: https://orcid.org/0000-0002-8232-3457)
- Stelian Ştefăniţă Mogoantă (ORCID: https://orcid.org/0000-0001-7576-9146)
- Laurențiu Augustus Barbu (ORCID: https://orcid.org/0009-0008-5822-8805)
- Tiberiu Ştefăniţă Ţenea-Cojan
- Valentina Căluianu
- Ioana Alexia Ţenea-Cojan
- Nicolae Dragoş Mărgăritescu
- Liviu Vasile
- Gabriel Florin Răzvan Mogoş
- Daniela Marinescu
Institutions
- University of Medicine and Pharmacy of Craiova (RO)
Publication Details
- Journal
- PubMed
- Published
- 2026-03-08
- DOI
- https://doi.org/10.47162/rjme.66.4.02
- Primary Topic
- Breast Cancer Treatment Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00